InFocus Therapeutics

Curated by Signal

AI platforms to design novel small molecule drugs targeting mRNA of genes associated with cancer, Alzheimer's, and other diseases

Health Technologyinfocustx.com

Overview

AI platforms to design novel small molecule drugs targeting mRNA of genes associated with cancer, Alzheimer's, and other diseases. It offers discovery platform to identify new RNA drugs on a scale and throughput and computational workflow transform pre-existing drugs into new, proprietary molecules with improved properties.

Key facts

Founded: 2023
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Agility Mat
Provider of an on-demand video training platform for fitness
Health TechnologyUnited States
Obento Health
Provider of an online store front platform for healthcare providers
Health TechnologySan Francisco, United States
EHR software
Provider of EHR software for behavioural health
Health TechnologyRoanoke, United States

About InFocus Therapeutics

What does InFocus Therapeutics do?

AI platforms to design novel small molecule drugs targeting mRNA of genes associated with cancer, Alzheimer's, and other diseases.

Where is InFocus Therapeutics headquartered?

InFocus Therapeutics is headquartered in Cambridge, United States.

When was InFocus Therapeutics founded?

InFocus Therapeutics was founded in 2023.

Which sector is InFocus Therapeutics in?

InFocus Therapeutics operates in Health Technology.

Who are InFocus Therapeutics's competitors?

Companies similar to InFocus Therapeutics include Agility Mat, Obento Health, and EHR software.